{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:43:03Z","timestamp":1793727783737,"version":"4.6.1"},"reference-count":247,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403125"],"award-info":[{"award-number":["82403125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273438"],"award-info":[{"award-number":["82273438"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the China State Key Basic Research Program Grant","award":["2024YFA1307204"],"award-info":[{"award-number":["2024YFA1307204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-025-00760-4","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T17:49:09Z","timestamp":1752774549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Posttranslational modifications of YAP\/TAZ: molecular mechanisms and therapeutic opportunities"],"prefix":"10.1186","volume":"30","author":[{"given":"Zhenxiong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"issue":"4","key":"760_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.340","volume":"4","author":"Y Wei","year":"2023","unstructured":"Wei Y, Hui VLZ, Chen Y, Han R, Han X, Guo Y. YAP\/TAZ: molecular pathway and disease therapy. MedComm. 2023;4(4): e340.","journal-title":"MedComm"},{"issue":"8","key":"760_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41568-023-00579-1","volume":"23","author":"JM Franklin","year":"2023","unstructured":"Franklin JM, Wu Z, Guan KL. Insights into recent findings and clinical application of YAP and TAZ in cancer. Nat Rev Cancer. 2023;23(8):512\u201325.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"760_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.trecan.2020.12.001","volume":"7","author":"YW Shen","year":"2021","unstructured":"Shen YW, Zhou YD, Chen HZ, Luan X, Zhang WD. Targeting CTGF in cancer: an emerging therapeutic opportunity. Trends Cancer. 2021;7(6):511\u201324.","journal-title":"Trends Cancer"},{"issue":"7","key":"760_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ncb1748","volume":"10","author":"X Varelas","year":"2008","unstructured":"Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol. 2008;10(7):837\u201348.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"760_CR5","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1158\/2159-8290.CD-17-1124","volume":"8","author":"X Ni","year":"2018","unstructured":"Ni X, Tao J, Barbi J, Chen Q, Park BV, Li Z, et al. YAP is essential for Treg-mediated suppression of antitumor immunity. Cancer Discov. 2018;8(8):1026\u201343.","journal-title":"Cancer Discov"},{"issue":"6","key":"760_CR6","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/cas.15352","volume":"113","author":"H Nishina","year":"2022","unstructured":"Nishina H. Physiological and pathological roles of the Hippo-YAP\/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis. Cancer Sci. 2022;113(6):1900\u20138.","journal-title":"Cancer Sci"},{"issue":"6","key":"760_CR7","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"J Dong","year":"2007","unstructured":"Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130(6):1120\u201333.","journal-title":"Cell"},{"issue":"8","key":"760_CR8","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1242\/dev.102376","volume":"141","author":"X Varelas","year":"2014","unstructured":"Varelas X. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development. 2014;141(8):1614\u201326.","journal-title":"Development"},{"issue":"8","key":"760_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41568-019-0168-y","volume":"19","author":"F Zanconato","year":"2019","unstructured":"Zanconato F, Cordenonsi M, Piccolo S. YAP and TAZ: a signalling hub of the tumour microenvironment. Nat Rev Cancer. 2019;19(8):454\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"760_CR10","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1038\/s41467-022-30831-5","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Zhuo S, Zhuang T, Cho YS, Wu G, Liu Y, et al. YAP inhibits ER\u03b1 and ER(+) breast cancer growth by disrupting a TEAD-ER\u03b1 signaling axis. Nat Commun. 2022;13(1):3075.","journal-title":"Nat Commun"},{"issue":"7769","key":"760_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572(7769):402\u20136.","journal-title":"Nature"},{"issue":"14","key":"760_CR12","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1038\/s41388-018-0610-8","volume":"38","author":"WW Pan","year":"2019","unstructured":"Pan WW, Moroishi T, Koo JH, Guan KL. Cell type-dependent function of LATS1\/2 in cancer cell growth. Oncogene. 2019;38(14):2595\u2013610.","journal-title":"Oncogene"},{"issue":"22","key":"760_CR13","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1182\/bloodadvances.2019000374","volume":"3","author":"S Grieve","year":"2019","unstructured":"Grieve S, Wajnberg G, Lees M, Chacko S, Weir J, Crapoulet N, et al. TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC. Blood Adv. 2019;3(22):3613\u201325.","journal-title":"Blood Adv"},{"issue":"8","key":"760_CR14","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ccell.2021.06.016","volume":"39","author":"JD Pearson","year":"2021","unstructured":"Pearson JD, Huang K, Pacal M, McCurdy SR, Lu S, Aubry A, et al. Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP\/TEAD activity. Cancer Cell. 2021;39(8):1115-34.e12.","journal-title":"Cancer Cell"},{"issue":"5","key":"760_CR15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/CIRCRESAHA.116.308586","volume":"119","author":"T Matsuda","year":"2016","unstructured":"Matsuda T, Zhai P, Sciarretta S, Zhang Y, Jeong JI, Ikeda S, et al. NF2 activates Hippo signaling and promotes ischemia\/reperfusion injury in the heart. Circ Res. 2016;119(5):596\u2013606.","journal-title":"Circ Res"},{"issue":"7675","key":"760_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nature24045","volume":"550","author":"JP Leach","year":"2017","unstructured":"Leach JP, Heallen T, Zhang M, Rahmani M, Morikawa Y, Hill MC, et al. Hippo pathway deficiency reverses systolic heart failure after infarction. Nature. 2017;550(7675):260\u20134.","journal-title":"Nature"},{"issue":"41","key":"760_CR17","doi-asserted-by":"publisher","first-page":"11525","DOI":"10.1073\/pnas.1613121113","volume":"113","author":"KC Wang","year":"2016","unstructured":"Wang KC, Yeh YT, Nguyen P, Limqueco E, Lopez J, Thorossian S, et al. Flow-dependent YAP\/TAZ activities regulate endothelial phenotypes and atherosclerosis. Proc Natl Acad Sci USA. 2016;113(41):11525\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"760_CR18","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/hep.30928","volume":"71","author":"M Mooring","year":"2020","unstructured":"Mooring M, Fowl BH, Lum SZC, Liu Y, Yao K, Softic S, et al. Hepatocyte stress increases expression of yes-associated protein and transcriptional coactivator with PDZ-binding motif in hepatocytes to promote parenchymal inflammation and fibrosis. Hepatology. 2020;71(5):1813\u201330.","journal-title":"Hepatology"},{"issue":"4","key":"760_CR19","doi-asserted-by":"publisher","first-page":"L344","DOI":"10.1152\/ajplung.00300.2014","volume":"308","author":"F Liu","year":"2015","unstructured":"Liu F, Lagares D, Choi KM, Stopfer L, Marinkovi\u0107 A, Vrbanac V, et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol. 2015;308(4):L344\u201357.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"760_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41467-020-14353-6","volume":"11","author":"H Tanaka","year":"2020","unstructured":"Tanaka H, Homma H, Fujita K, Kondo K, Yamada S, Jin X, et al. YAP-dependent necrosis occurs in early stages of Alzheimer\u2019s disease and regulates mouse model pathology. Nat Commun. 2020;11(1):507.","journal-title":"Nat Commun"},{"issue":"6","key":"760_CR21","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1089\/dna.2019.5308","volume":"39","author":"J Qing","year":"2020","unstructured":"Qing J, Liu X, Wu Q, Zhou M, Zhang Y, Mazhar M, et al. Hippo\/YAP pathway plays a critical role in effect of GDNF against A\u03b2-induced inflammation in microglial cells. DNA Cell Biol. 2020;39(6):1064\u201371.","journal-title":"DNA Cell Biol"},{"issue":"3","key":"760_CR22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.cmet.2018.02.005","volume":"27","author":"KM Tharp","year":"2018","unstructured":"Tharp KM, Kang MS, Timblin GA, Dempersmier J, Dempsey GE, Zushin PH, et al. Actomyosin-mediated tension orchestrates uncoupled respiration in adipose tissues. Cell Metab. 2018;27(3):602-15.e4.","journal-title":"Cell Metab"},{"issue":"1","key":"760_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cmet.2019.10.003","volume":"31","author":"D El Ouarrat","year":"2020","unstructured":"El Ouarrat D, Isaac R, Lee YS, Oh DY, Wollam J, Lackey D, et al. TAZ is a negative regulator of PPAR\u03b3 activity in adipocytes and TAZ deletion improves insulin sensitivity and glucose tolerance. Cell Metab. 2020;31(1):162-73.e5.","journal-title":"Cell Metab"},{"issue":"1","key":"760_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13046-023-02704-2","volume":"42","author":"J Luo","year":"2023","unstructured":"Luo J, Deng L, Zou H, Guo Y, Tong T, Huang M, et al. New insights into the ambivalent role of YAP\/TAZ in human cancers. J Exp Clin Cancer Res. 2023;42(1):130.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"760_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.tcb.2024.04.009","volume":"34","author":"KM Kiang","year":"2024","unstructured":"Kiang KM, Ahad L, Zhong X, Lu QR. Biomolecular condensates: hubs of Hippo-YAP\/TAZ signaling in cancer. Trends Cell Biol. 2024;34(7):566\u201377.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"760_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","volume":"15","author":"T Moroishi","year":"2015","unstructured":"Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15(2):73\u20139.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"760_CR27","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1038\/s41467-018-04590-1","volume":"9","author":"D Martin","year":"2018","unstructured":"Martin D, Degese MS, Vitale-Cross L, Iglesias-Bartolome R, Valera JLC, Wang Z, et al. Assembly and activation of the Hippo signalome by FAT1 tumor suppressor. Nat Commun. 2018;9(1):2372.","journal-title":"Nat Commun"},{"issue":"7842","key":"760_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41586-020-03046-1","volume":"589","author":"I Pastushenko","year":"2021","unstructured":"Pastushenko I, Mauri F, Song Y, de Cock F, Meeusen B, Swedlund B, et al. Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis. Nature. 2021;589(7842):448\u201355.","journal-title":"Nature"},{"key":"760_CR29","doi-asserted-by":"crossref","unstructured":"Karaman R, Halder G. Cell junctions in hippo signaling. Cold Spring Harb Perspect Biol. 2018;10(5).","DOI":"10.1101\/cshperspect.a028753"},{"issue":"3","key":"760_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.devcel.2015.06.020","volume":"34","author":"AD Szymaniak","year":"2015","unstructured":"Szymaniak AD, Mahoney JE, Cardoso WV, Varelas X. Crumbs3-mediated polarity directs airway epithelial cell fate through the hippo pathway effector Yap. Dev Cell. 2015;34(3):283\u201396.","journal-title":"Dev Cell"},{"issue":"1","key":"760_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13046-017-0609-y","volume":"36","author":"PJ Zhou","year":"2017","unstructured":"Zhou PJ, Xue W, Peng J, Wang Y, Wei L, Yang Z, et al. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3\/aPKC\/KIBRA complex and inactivating the hippo pathway. J Exp Clin Cancer Res. 2017;36(1):139.","journal-title":"J Exp Clin Cancer Res"},{"key":"760_CR32","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1038\/celldisc.2016.21","volume":"2","author":"P Zhang","year":"2016","unstructured":"Zhang P, Wang S, Wang S, Qiao J, Zhang L, Zhang Z, et al. Dual function of partitioning-defective 3 in the regulation of YAP phosphorylation and activation. Cell Discov. 2016;2:16021.","journal-title":"Cell Discov"},{"issue":"1","key":"760_CR33","doi-asserted-by":"publisher","first-page":"10381","DOI":"10.1038\/s41467-024-54645-9","volume":"15","author":"SS Guo","year":"2024","unstructured":"Guo SS, Liu Z, Wang GM, Sun Z, Yu K, Fawcett JP, et al. KANK1 promotes breast cancer development by compromising Scribble-mediated Hippo activation. Nat Commun. 2024;15(1):10381.","journal-title":"Nat Commun"},{"key":"760_CR34","doi-asserted-by":"publisher","first-page":"42125","DOI":"10.1038\/srep42125","volume":"7","author":"J Liu","year":"2017","unstructured":"Liu J, Li J, Li P, Wang Y, Liang Z, Jiang Y, et al. Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway. Sci Rep. 2017;7:42125.","journal-title":"Sci Rep"},{"issue":"1","key":"760_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. Signal Transduct Target Ther. 2024;9(1):88.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"760_CR36","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","volume":"150","author":"FX Yu","year":"2012","unstructured":"Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150(4):780\u201391.","journal-title":"Cell"},{"issue":"1","key":"760_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1478-811X-11-31","volume":"11","author":"H Cai","year":"2013","unstructured":"Cai H, Xu Y. The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells. Cell Commun Signal. 2013;11(1):31.","journal-title":"Cell Commun Signal"},{"key":"760_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.canlet.2018.07.021","volume":"434","author":"S Saikawa","year":"2018","unstructured":"Saikawa S, Kaji K, Nishimura N, Seki K, Sato S, Nakanishi K, et al. Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein. Cancer Lett. 2018;434:120\u20139.","journal-title":"Cancer Lett"},{"issue":"18","key":"760_CR39","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-16-3125","volume":"77","author":"C Dethlefsen","year":"2017","unstructured":"Dethlefsen C, Hansen LS, Lillelund C, Andersen C, Gehl J, Christensen JF, et al. Exercise-induced catecholamines activate the hippo tumor suppressor pathway to reduce risks of breast cancer development. Cancer Res. 2017;77(18):4894\u2013904.","journal-title":"Cancer Res"},{"key":"760_CR40","doi-asserted-by":"crossref","unstructured":"Luo J, Yu FX. GPCR-hippo signaling in cancer. Cells. 2019;8(5).","DOI":"10.3390\/cells8050426"},{"issue":"7350","key":"760_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP\/TAZ in mechanotransduction. Nature. 2011;474(7350):179\u201383.","journal-title":"Nature"},{"issue":"12","key":"760_CR42","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/s41556-019-0426-y","volume":"21","author":"R Chen","year":"2019","unstructured":"Chen R, Xie R, Meng Z, Ma S, Guan KL. STRIPAK integrates upstream signals to initiate the Hippo kinase cascade. Nat Cell Biol. 2019;21(12):1565\u201377.","journal-title":"Nat Cell Biol"},{"key":"760_CR43","first-page":"138","volume":"27","author":"X Wang","year":"2023","unstructured":"Wang X, Ji L, Wang J, Liu C. Matrix stiffness regulates osteoclast fate through integrin-dependent mechanotransduction. Bioact Mater. 2023;27:138\u201353.","journal-title":"Bioact Mater"},{"issue":"3","key":"760_CR44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1083\/jcb.201501025","volume":"210","author":"NG Kim","year":"2015","unstructured":"Kim NG, Gumbiner BM. Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway. J Cell Biol. 2015;210(3):503\u201315.","journal-title":"J Cell Biol"},{"issue":"9","key":"760_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111296","volume":"40","author":"Y Gu","year":"2022","unstructured":"Gu Y, Wang Y, Sha Z, He C, Zhu Y, Li J, et al. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP\/TAZ-active cancers. Cell Rep. 2022;40(9): 111296.","journal-title":"Cell Rep"},{"issue":"1","key":"760_CR46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.15252\/embr.201642681","volume":"18","author":"AW Hong","year":"2017","unstructured":"Hong AW, Meng Z, Yuan HX, Plouffe SW, Moon S, Kim W, et al. Osmotic stress-induced phosphorylation by NLK at Ser128 activates YAP. EMBO Rep. 2017;18(1):72\u201386.","journal-title":"EMBO Rep"},{"key":"760_CR47","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1038\/ncomms4315","volume":"5","author":"D Shao","year":"2014","unstructured":"Shao D, Zhai P, Del Re DP, Sciarretta S, Yabuta N, Nojima H, et al. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun. 2014;5:3315.","journal-title":"Nat Commun"},{"issue":"4","key":"760_CR48","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ncb3111","volume":"17","author":"JS Mo","year":"2015","unstructured":"Mo JS, Meng Z, Kim YC, Park HW, Hansen CG, Kim S, et al. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol. 2015;17(4):500\u201310.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"760_CR49","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/ncb3113","volume":"17","author":"W Wang","year":"2015","unstructured":"Wang W, Xiao ZD, Li X, Aziz KE, Gan B, Johnson RL, et al. AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol. 2015;17(4):490\u20139.","journal-title":"Nat Cell Biol"},{"key":"760_CR50","doi-asserted-by":"crossref","unstructured":"Zhong B, Liu J, Ong HH, Du J, Liu F, Liu Y, et al. Hypoxia-reduced YAP phosphorylation enhances expression of Mucin5AC in nasal epithelial cells of chronic rhinosinusitis with nasal polyps. Allergy. 2024.","DOI":"10.1111\/all.16394"},{"issue":"1","key":"760_CR51","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41467-023-44542-y","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Zhou H, Huang X, Wu C, Zheng K, Deng J, et al. Innate immune and proinflammatory signals activate the Hippo pathway via a Tak1-STRIPAK-Tao axis. Nat Commun. 2024;15(1):145.","journal-title":"Nat Commun"},{"issue":"23","key":"760_CR52","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.3748\/wjg.v20.i23.7381","volume":"20","author":"K Miura","year":"2014","unstructured":"Miura K, Ohnishi H. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(23):7381\u201391.","journal-title":"World J Gastroenterol"},{"issue":"31","key":"760_CR53","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1038\/onc.2015.476","volume":"35","author":"L Li","year":"2016","unstructured":"Li L, Fang R, Liu B, Shi H, Wang Y, Zhang W, et al. Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth. Oncogene. 2016;35(31):4048\u201357.","journal-title":"Oncogene"},{"issue":"19","key":"760_CR54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176828","volume":"134","author":"X Lin","year":"2024","unstructured":"Lin X, Chen W, Yang G, Zhang J, Wang H, Liu Z, et al. Viral infection induces inflammatory signals that coordinate YAP regulation of dysplastic cells in lung alveoli. J Clin Invest. 2024;134(19): e176828.","journal-title":"J Clin Invest"},{"issue":"5","key":"760_CR55","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jaci.2024.07.006","volume":"154","author":"H Qiu","year":"2024","unstructured":"Qiu H, Liu J, Wu Q, Ong H, Zhang Y, Huang X, et al. An in vitro study of the impact of IL-17A and IL-22 on ciliogenesis in nasal polyps epithelium via the Hippo-YAP pathway. J Allergy Clin Immunol. 2024;154(5):1180\u201394.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"760_CR56","doi-asserted-by":"publisher","first-page":"7018","DOI":"10.1074\/jbc.C110.212621","volume":"286","author":"SW Chan","year":"2011","unstructured":"Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem. 2011;286(9):7018\u201326.","journal-title":"J Biol Chem"},{"issue":"6","key":"760_CR57","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1074\/jbc.C110.205401","volume":"286","author":"W Wang","year":"2011","unstructured":"Wang W, Huang J, Chen J. Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem. 2011;286(6):4364\u201370.","journal-title":"J Biol Chem"},{"issue":"6","key":"760_CR58","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ccr.2014.04.016","volume":"25","author":"X Feng","year":"2014","unstructured":"Feng X, Degese MS, Iglesias-Bartolome R, Vaque JP, Molinolo AA, Rodrigues M, et al. Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell. 2014;25(6):831\u201345.","journal-title":"Cancer Cell"},{"issue":"7730","key":"760_CR59","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-018-0658-1","volume":"563","author":"L Chang","year":"2018","unstructured":"Chang L, Azzolin L, Di Biagio D, Zanconato F, Battilana G, Lucon Xiccato R, et al. The SWI\/SNF complex is a mechanoregulated inhibitor of YAP and TAZ. Nature. 2018;563(7730):265\u20139.","journal-title":"Nature"},{"issue":"1","key":"760_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.15252\/embr.201642683","volume":"18","author":"S Moon","year":"2017","unstructured":"Moon S, Kim W, Kim S, Kim Y, Song Y, Bilousov O, et al. Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization. EMBO Rep. 2017;18(1):61\u201371.","journal-title":"EMBO Rep"},{"key":"760_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.856247","volume":"13","author":"R Caire","year":"2022","unstructured":"Caire R, Dalix E, Chafchafi M, Thomas M, Linossier MT, Normand M, et al. YAP transcriptional activity dictates cell response to TNF in vitro. Front Immunol. 2022;13: 856247.","journal-title":"Front Immunol"},{"issue":"6","key":"760_CR62","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.cell.2017.10.008","volume":"171","author":"A Elosegui-Artola","year":"2017","unstructured":"Elosegui-Artola A, Andreu I, Beedle AEM, Lezamiz A, Uroz M, Kosmalska AJ, et al. Force triggers YAP nuclear entry by regulating transport across nuclear pores. Cell. 2017;171(6):1397-410.e14.","journal-title":"Cell"},{"issue":"7","key":"760_CR63","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.cell.2012.11.027","volume":"151","author":"L Azzolin","year":"2012","unstructured":"Azzolin L, Zanconato F, Bresolin S, Forcato M, Basso G, Bicciato S, et al. Role of TAZ as mediator of Wnt signaling. Cell. 2012;151(7):1443\u201356.","journal-title":"Cell"},{"issue":"1","key":"760_CR64","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41467-017-02786-5","volume":"9","author":"A Papaspyropoulos","year":"2018","unstructured":"Papaspyropoulos A, Bradley L, Thapa A, Leung CY, Toskas K, Koennig D, et al. RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73. Nat Commun. 2018;9(1):424.","journal-title":"Nat Commun"},{"issue":"2","key":"760_CR65","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2012.05.036","volume":"150","author":"P Beltrao","year":"2012","unstructured":"Beltrao P, Alban\u00e8se V, Kenner LR, Swaney DL, Burlingame A, Vill\u00e9n J, et al. Systematic functional prioritization of protein posttranslational modifications. Cell. 2012;150(2):413\u201325.","journal-title":"Cell"},{"issue":"12","key":"760_CR66","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41577-023-00877-7","volume":"23","author":"L Castelo-Soccio","year":"2023","unstructured":"Castelo-Soccio L, Kim H, Gadina M, Schwartzberg PL, Laurence A, O\u2019Shea JJ. Protein kinases: drug targets for immunological disorders. Nat Rev Immunol. 2023;23(12):787\u2013806.","journal-title":"Nat Rev Immunol"},{"issue":"21","key":"760_CR67","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21(21):2747\u201361.","journal-title":"Genes Dev"},{"issue":"9","key":"760_CR68","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1074\/jbc.M709037200","volume":"283","author":"Y Hao","year":"2008","unstructured":"Hao Y, Chun A, Cheung K, Rashidi B, Yang X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem. 2008;283(9):5496\u2013509.","journal-title":"J Biol Chem"},{"issue":"1","key":"760_CR69","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.1843810","volume":"24","author":"B Zhao","year":"2010","unstructured":"Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev. 2010;24(1):72\u201385.","journal-title":"Genes Dev"},{"issue":"7","key":"760_CR70","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1128\/MCB.01874-07","volume":"28","author":"QY Lei","year":"2008","unstructured":"Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, et al. TAZ promotes cell proliferation and epithelial\u2013mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol. 2008;28(7):2426\u201336.","journal-title":"Mol Cell Biol"},{"issue":"48","key":"760_CR71","doi-asserted-by":"publisher","first-page":"37159","DOI":"10.1074\/jbc.M110.152942","volume":"285","author":"CY Liu","year":"2010","unstructured":"Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D, et al. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. J Biol Chem. 2010;285(48):37159\u201369.","journal-title":"J Biol Chem"},{"issue":"3","key":"760_CR72","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cub.2014.11.054","volume":"25","author":"L Zhang","year":"2015","unstructured":"Zhang L, Tang F, Terracciano L, Hynx D, Kohler R, Bichet S, et al. NDR functions as a physiological YAP1 kinase in the intestinal epithelium. Curr Biol. 2015;25(3):296\u2013305.","journal-title":"Curr Biol"},{"issue":"8","key":"760_CR73","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.joca.2023.04.006","volume":"31","author":"Y Cui","year":"2023","unstructured":"Cui Y, Miao MZ, Wang M, Su QP, Qiu K, Arbeeva L, et al. Yes-associated protein nuclear translocation promotes anabolic activity in human articular chondrocytes. Osteoarthritis Cartilage. 2023;31(8):1078\u201390.","journal-title":"Osteoarthritis Cartilage"},{"issue":"31","key":"760_CR74","doi-asserted-by":"publisher","first-page":"26245","DOI":"10.1074\/jbc.M112.382036","volume":"287","author":"W Huang","year":"2012","unstructured":"Huang W, Lv X, Liu C, Zha Z, Zhang H, Jiang Y, et al. The N-terminal phosphodegron targets TAZ\/WWTR1 protein for SCF\u03b2-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition. J Biol Chem. 2012;287(31):26245\u201353.","journal-title":"J Biol Chem"},{"issue":"12","key":"760_CR75","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/neuonc\/noac156","volume":"24","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang K, Fu J, Zhang Y, Mao Y, Wang X, et al. FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1. Neuro Oncol. 2022;24(12):2107\u201320.","journal-title":"Neuro Oncol"},{"issue":"1","key":"760_CR76","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1038\/s41467-018-07022-2","volume":"9","author":"Y Deng","year":"2018","unstructured":"Deng Y, Lu J, Li W, Wu A, Zhang X, Tong W, et al. Reciprocal inhibition of YAP\/TAZ and NF-\u03baB regulates osteoarthritic cartilage degradation. Nat Commun. 2018;9(1):4564.","journal-title":"Nat Commun"},{"issue":"7","key":"760_CR77","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ni.3744","volume":"18","author":"S Wang","year":"2017","unstructured":"Wang S, Xie F, Chu F, Zhang Z, Yang B, Dai T, et al. YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKvarepsilon-mediated phosphorylation. Nat Immunol. 2017;18(7):733\u201343.","journal-title":"Nat Immunol"},{"issue":"2","key":"760_CR78","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41388-019-0988-y","volume":"39","author":"T Azad","year":"2020","unstructured":"Azad T, Nouri K, Janse van Rensburg HJ, Maritan SM, Wu L, Hao Y, et al. A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis. Oncogene. 2020;39(2):334\u201355.","journal-title":"Oncogene"},{"issue":"7","key":"760_CR79","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1002\/ijc.32609","volume":"146","author":"C Huang","year":"2020","unstructured":"Huang C, Yuan W, Lai C, Zhong S, Yang C, Wang R, et al. EphA2-to-YAP pathway drives gastric cancer growth and therapy resistance. Int J Cancer. 2020;146(7):1937\u201349.","journal-title":"Int J Cancer"},{"issue":"7","key":"760_CR80","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1096\/fj.201601090R","volume":"31","author":"TH Chen","year":"2017","unstructured":"Chen TH, Chen CY, Wen HC, Chang CC, Wang HD, Chuu CP, et al. YAP promotes myogenic differentiation via the MEK5-ERK5 pathway. FASEB J. 2017;31(7):2963\u201372.","journal-title":"FASEB J"},{"issue":"4","key":"760_CR81","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s12276-024-01210-5","volume":"56","author":"S Park","year":"2024","unstructured":"Park S, Ryu WJ, Kim TY, Hwang Y, Han HJ, Lee JD, et al. Overcoming BRAF and CDK4\/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation. Exp Mol Med. 2024;56(4):987\u20131000.","journal-title":"Exp Mol Med"},{"issue":"12","key":"760_CR82","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.3390\/cancers12123666","volume":"12","author":"MI Khalil","year":"2020","unstructured":"Khalil MI, Ghosh I, Singh V, Chen J, Zhu H, De Benedetti A. NEK1 phosphorylation of YAP promotes its stabilization and transcriptional output. Cancers (Basel). 2020;12(12):3666.","journal-title":"Cancers (Basel)."},{"issue":"1","key":"760_CR83","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12964-022-00898-0","volume":"20","author":"W Su","year":"2022","unstructured":"Su W, Hu H, Ding Q, Wang M, Zhu Y, Zhang Z, et al. NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143. Cell Commun Signal. 2022;20(1):87.","journal-title":"Cell Commun Signal"},{"key":"760_CR84","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1158\/2159-8290.CD-23-1529","volume":"14","author":"O Klingbeil","year":"2024","unstructured":"Klingbeil O, Skopelitis D, Tonelli C, Yoshimoto T, Alpsoy A, Panepinto MC, et al. MARK2\/MARK3 kinases are catalytic co-dependencies of YAP\/TAZ in human cancer. Cancer Discov. 2024;14:2471.","journal-title":"Cancer Discov"},{"issue":"1","key":"760_CR85","doi-asserted-by":"publisher","first-page":"2192501","DOI":"10.1080\/19490976.2023.2192501","volume":"15","author":"N Li","year":"2023","unstructured":"Li N, Xu X, Zhan Y, Fei X, Ouyang Y, Zheng P, et al. YAP and \u03b2-catenin cooperate to drive H. pylori-induced gastric tumorigenesis. Gut Microbes. 2023;15(1):2192501.","journal-title":"Gut Microbes."},{"issue":"9","key":"760_CR86","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.neo.2021.07.005","volume":"23","author":"B Holmes","year":"2021","unstructured":"Holmes B, Benavides-Serrato A, Saunders JT, Kumar S, Nishimura RN, Gera J. mTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasive characteristics. Neoplasia. 2021;23(9):951\u201365.","journal-title":"Neoplasia"},{"issue":"32","key":"760_CR87","doi-asserted-by":"publisher","first-page":"19387","DOI":"10.1074\/jbc.M115.656587","volume":"290","author":"N Artinian","year":"2015","unstructured":"Artinian N, Cloninger C, Holmes B, Benavides-Serrato A, Bashir T, Gera J. Phosphorylation of the hippo pathway component AMOTL2 by the mTORC2 kinase promotes YAP signaling, resulting in enhanced glioblastoma growth and invasiveness. J Biol Chem. 2015;290(32):19387\u2013401.","journal-title":"J Biol Chem"},{"issue":"4","key":"760_CR88","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1158\/0008-5472.CAN-24-0456","volume":"85","author":"RE Turnham","year":"2025","unstructured":"Turnham RE, Pitea A, Jang GM, Xu Z, Lim HC, Choi AL, et al. HBV remodels PP2A complexes to rewire kinase signaling in hepatocellular carcinoma. Cancer Res. 2025;85(4):660\u201374.","journal-title":"Cancer Res"},{"issue":"9","key":"760_CR89","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41419-024-07077-8","volume":"15","author":"B Son","year":"2024","unstructured":"Son B, Lee W, Kim H, Shin H, Park HH. Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research. Cell Death Dis. 2024;15(9):696.","journal-title":"Cell Death Dis"},{"issue":"9","key":"760_CR90","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/onc.2016.292","volume":"36","author":"SS Chang","year":"2016","unstructured":"Chang SS, Yamaguchi H, Xia W, Lim SO, Khotskaya Y, Wu Y, et al. Aurora A kinase activates YAP signaling in triple-negative breast cancer. Oncogene. 2016;36(9):1265\u201375.","journal-title":"Oncogene"},{"issue":"6","key":"760_CR91","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41419-019-1664-4","volume":"10","author":"P Wang","year":"2019","unstructured":"Wang P, Gong Y, Guo T, Li M, Fang L, Yin S, et al. Activation of Aurora A kinase increases YAP stability via blockage of autophagy. Cell Death Dis. 2019;10(6):432.","journal-title":"Cell Death Dis"},{"issue":"8","key":"760_CR92","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/s41416-024-02649-z","volume":"130","author":"A Rio-Vilari\u00f1o","year":"2024","unstructured":"Rio-Vilari\u00f1o A, Cenigaonandia-Campillo A, Garc\u00eda-Bautista A, Mateos-G\u00f3mez PA, Schlaepfer MI, Del Puerto-Nevado L, et al. Inhibition of the AURKA\/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. Br J Cancer. 2024;130(8):1402\u201313.","journal-title":"Br J Cancer"},{"issue":"1","key":"760_CR93","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41392-023-01555-9","volume":"8","author":"M Lv","year":"2023","unstructured":"Lv M, Gong Y, Liu X, Wang Y, Wu Q, Chen J, et al. CDK7-YAP-LDHD axis promotes d-lactate elimination and ferroptosis defense to support cancer stem cell-like properties. Signal Transduct Target Ther. 2023;8(1):302.","journal-title":"Signal Transduct Target Ther"},{"key":"760_CR94","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ceb.2017.02.011","volume":"45","author":"B Wang","year":"2017","unstructured":"Wang B, Kundu M. Canonical and noncanonical functions of ULK\/Atg1. Curr Opin Cell Biol. 2017;45:47\u201354.","journal-title":"Curr Opin Cell Biol"},{"issue":"11","key":"760_CR95","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.7150\/ijbs.60018","volume":"17","author":"Y Jia","year":"2021","unstructured":"Jia Y, Li HY, Wang Y, Wang J, Zhu JW, Wei YY, et al. Crosstalk between hypoxia-sensing ULK1\/2 and YAP-driven glycolysis fuels pancreatic ductal adenocarcinoma development. Int J Biol Sci. 2021;17(11):2772\u201394.","journal-title":"Int J Biol Sci"},{"key":"760_CR96","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1158\/1078-0432.CCR-24-1834","volume":"30","author":"F Facchinetti","year":"2024","unstructured":"Facchinetti F, Loriot Y, Braye F, Vasseur D, Bahleda R, Bigot L, et al. Understanding and overcoming resistance to selective FGFR inhibitors across FGFR2-driven malignancies. Clin Cancer Res. 2024;30:4943.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"760_CR97","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s40265-024-02040-5","volume":"84","author":"MF Chen","year":"2024","unstructured":"Chen MF, Repetto M, Wilhelm C, Drilon A. RET inhibitors in RET fusion-positive lung cancers: past, present, and future. Drugs. 2024;84(9):1035\u201353.","journal-title":"Drugs"},{"issue":"1","key":"760_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166586","volume":"1869","author":"C Liang","year":"2023","unstructured":"Liang C, Zhu D, Xia W, Hong Z, Wang QS, Sun Y, et al. Inhibition of YAP by lenvatinib in endothelial cells increases blood pressure through ferroptosis. Biochim Biophys Acta Mol Basis Dis. 2023;1869(1): 166586.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"760_CR99","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191817","volume":"217","author":"L An","year":"2020","unstructured":"An L, Nie P, Chen M, Tang Y, Zhang H, Guan J, et al. MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway. J Exp Med. 2020;217(6): e20191817.","journal-title":"J Exp Med"},{"issue":"1","key":"760_CR100","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s41467-018-04090-2","volume":"9","author":"YS Cho","year":"2018","unstructured":"Cho YS, Zhu J, Li S, Wang B, Han Y, Jiang J. Regulation of Yki\/Yap subcellular localization and Hpo signaling by a nuclear kinase PRP4K. Nat Commun. 2018;9(1):1657.","journal-title":"Nat Commun"},{"issue":"10","key":"760_CR101","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1158\/1541-7786.MCR-18-0158","volume":"16","author":"T Sugihara","year":"2018","unstructured":"Sugihara T, Werneburg NW, Hernandez MC, Yang L, Kabashima A, Hirsova P, et al. YAP tyrosine phosphorylation and nuclear localization in cholangiocarcinoma cells are regulated by LCK and independent of LATS activity. Mol Cancer Res. 2018;16(10):1556\u201367.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"760_CR102","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jhep.2022.09.014","volume":"78","author":"CB Conboy","year":"2023","unstructured":"Conboy CB, Yonkus JA, Buckarma EH, Mun DG, Werneburg NW, Watkins RD, et al. LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma. J Hepatol. 2023;78(1):142\u201352.","journal-title":"J Hepatol"},{"issue":"1","key":"760_CR103","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41467-024-45750-w","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Wang D, Zhou L, Zhou N, Wang Z, Chen J, et al. Cell softness renders cytotoxic T lymphocytes and T leukemic cells resistant to perforin-mediated killing. Nat Commun. 2024;15(1):1405.","journal-title":"Nat Commun"},{"issue":"4","key":"760_CR104","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jhep.2021.05.018","volume":"75","author":"X Song","year":"2021","unstructured":"Song X, Xu H, Wang P, Wang J, Affo S, Wang H, et al. Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. J Hepatol. 2021;75(4):888\u201399.","journal-title":"J Hepatol"},{"issue":"1","key":"760_CR105","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.stem.2017.03.023","volume":"21","author":"JK Hu","year":"2017","unstructured":"Hu JK, Du W, Shelton SJ, Oldham MC, DiPersio CM, Klein OD. An FAK-YAP-mTOR signaling axis regulates stem cell-based tissue renewal in mice. Cell Stem Cell. 2017;21(1):91-106.e6.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"760_CR106","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1101\/gad.274951.115","volume":"30","author":"P Li","year":"2016","unstructured":"Li P, Silvis MR, Honaker Y, Lien WH, Arron ST, Vasioukhin V. \u03b1E-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway. Genes Dev. 2016;30(7):798\u2013811.","journal-title":"Genes Dev"},{"issue":"20","key":"760_CR107","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2219755120","volume":"120","author":"DR Singh","year":"2023","unstructured":"Singh DR, Nelson SE, Pawelski AS, Kansra AS, Fogarty SA, Bristol JA, et al. Epstein\u2013Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ. Proc Natl Acad Sci USA. 2023;120(20): e2219755120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"760_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127757","volume":"34","author":"M Guo","year":"2021","unstructured":"Guo M, Dai S, Wu D, Duan Y, Li J, Qu L, et al. Characterization of ibrutinib as a non-covalent inhibitor of SRC-family kinases. Bioorg Med Chem Lett. 2021;34: 127757.","journal-title":"Bioorg Med Chem Lett"},{"key":"760_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101051","volume":"73","author":"H Zou","year":"2024","unstructured":"Zou H, Luo J, Guo Y, Deng L, Zeng L, Pan Y, et al. Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer. Drug Resist Updat. 2024;73: 101051.","journal-title":"Drug Resist Updat"},{"issue":"8","key":"760_CR110","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/bph.16007","volume":"180","author":"H Ding","year":"2023","unstructured":"Ding H, Jiang M, Lau CW, Luo J, Chan AM, Wang L, et al. Curaxin CBL0137 inhibits endothelial inflammation and atherogenesis via suppression of the Src-YAP signalling axis. Br J Pharmacol. 2023;180(8):1168\u201385.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"760_CR111","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/sj.emboj.7600073","volume":"23","author":"SK Zaidi","year":"2004","unstructured":"Zaidi SK, Sullivan AJ, Medina R, Ito Y, van Wijnen AJ, Stein JL, et al. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. Embo J. 2004;23(4):790\u20139.","journal-title":"Embo J"},{"issue":"717","key":"760_CR112","doi-asserted-by":"publisher","first-page":"eabj4743","DOI":"10.1126\/scisignal.abj4743","volume":"15","author":"JP Gu\u00e9gan","year":"2022","unstructured":"Gu\u00e9gan JP, Lapouge M, Voisin L, Saba-El-Leil MK, Tanguay PL, L\u00e9vesque K, et al. Signaling by the tyrosine kinase Yes promotes liver cancer development. Sci Signal. 2022;15(717):eabj4743.","journal-title":"Sci Signal."},{"issue":"7","key":"760_CR113","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.cell.2012.11.026","volume":"151","author":"J Rosenbluh","year":"2012","unstructured":"Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, et al. \u03b2-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell. 2012;151(7):1457\u201373.","journal-title":"Cell"},{"issue":"17","key":"760_CR114","doi-asserted-by":"publisher","first-page":"10119","DOI":"10.3390\/ijms231710119","volume":"23","author":"Q Liu","year":"2022","unstructured":"Liu Q, Stel WV, Noord VEV, Leegwater H, Coban B, Elbertse K, et al. Hypoxia triggers TAZ phosphorylation in basal A triple negative breast cancer cells. Int J Mol Sci. 2022;23(17):10119.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"760_CR115","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.molcel.2007.12.022","volume":"29","author":"D Levy","year":"2008","unstructured":"Levy D, Adamovich Y, Reuven N, Shaul Y. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell. 2008;29(3):350\u201361.","journal-title":"Mol Cell"},{"issue":"3","key":"760_CR116","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI122440","volume":"129","author":"B Li","year":"2019","unstructured":"Li B, He J, Lv H, Liu Y, Lv X, Zhang C, et al. c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow. J Clin Invest. 2019;129(3):1167\u201379.","journal-title":"J Clin Invest"},{"issue":"1","key":"760_CR117","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41419-024-06465-4","volume":"15","author":"CL Kim","year":"2024","unstructured":"Kim CL, Lim SB, Choi SH, Kim DH, Sim YE, Jo EH, et al. The LKB1-TSSK1B axis controls YAP phosphorylation to regulate the Hippo-YAP pathway. Cell Death Dis. 2024;15(1):76.","journal-title":"Cell Death Dis"},{"issue":"2","key":"760_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2010.7","volume":"1","author":"V Tomlinson","year":"2010","unstructured":"Tomlinson V, Gudmundsdottir K, Luong P, Leung KY, Knebel A, Basu S. JNK phosphorylates yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis. 2010;1(2): e29.","journal-title":"Cell Death Dis"},{"issue":"22","key":"760_CR119","doi-asserted-by":"publisher","first-page":"6722","DOI":"10.1158\/0008-5472.CAN-13-2049","volume":"73","author":"S Yang","year":"2013","unstructured":"Yang S, Zhang L, Liu M, Chong R, Ding SJ, Chen Y, et al. CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation. Cancer Res. 2013;73(22):6722\u201333.","journal-title":"Cancer Res"},{"issue":"16","key":"760_CR120","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1158\/0008-5472.CAN-13-2712","volume":"74","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Khanal P, Savage P, She YM, Cyr TD, Yang X. YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway. Cancer Res. 2014;74(16):4493\u2013503.","journal-title":"Cancer Res"},{"issue":"29","key":"760_CR121","doi-asserted-by":"publisher","first-page":"E6760","DOI":"10.1073\/pnas.1800621115","volume":"115","author":"J Zhou","year":"2018","unstructured":"Zhou J, Zeng Y, Cui L, Chen X, Stauffer S, Wang Z, et al. Zyxin promotes colon cancer tumorigenesis in a mitotic phosphorylation-dependent manner and through CDK8-mediated YAP activation. Proc Natl Acad Sci USA. 2018;115(29):E6760\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"760_CR122","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1111\/bph.15378","volume":"178","author":"Y Yang","year":"2021","unstructured":"Yang Y, Ma Q, Li Z, Wang H, Zhang C, Liu Y, et al. Harmine alleviates atherogenesis by inhibiting disturbed flow-mediated endothelial activation via protein tyrosine phosphatase PTPN14 and YAP. Br J Pharmacol. 2021;178(7):1524\u201340.","journal-title":"Br J Pharmacol"},{"issue":"18","key":"760_CR123","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1080\/15384101.2016.1207836","volume":"15","author":"YW Li","year":"2016","unstructured":"Li YW, Guo J, Shen H, Li J, Yang N, Frangou C, et al. Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation. Cell Cycle. 2016;15(18):2497\u2013505.","journal-title":"Cell Cycle"},{"key":"760_CR124","doi-asserted-by":"crossref","unstructured":"Choi S. Encyclopedia of signaling. Molecules. 2018.","DOI":"10.1007\/978-3-319-67199-4"},{"issue":"7","key":"760_CR125","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.1074\/jbc.M110.194019","volume":"286","author":"CY Liu","year":"2011","unstructured":"Liu CY, Lv X, Li T, Xu Y, Zhou X, Zhao S, et al. PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ. J Biol Chem. 2011;286(7):5558\u201366.","journal-title":"J Biol Chem"},{"issue":"1","key":"760_CR126","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s13046-023-02915-7","volume":"42","author":"Z Chen","year":"2023","unstructured":"Chen Z, Li Y, He K, Yang J, Deng Q, Chen Y, et al. CircGPRC5A enhances colorectal cancer progress by stabilizing PPP1CA and inducing YAP dephosphorylation. J Exp Clin Cancer Res. 2023;42(1):334.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"760_CR127","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41389-019-0172-9","volume":"8","author":"AL Hein","year":"2019","unstructured":"Hein AL, Brandquist ND, Ouellette CY, Seshacharyulu P, Enke CA, Ouellette MM, et al. PR55\u03b1 regulatory subunit of PP2A inhibits the MOB1\/LATS cascade and activates YAP in pancreatic cancer cells. Oncogenesis. 2019;8(11):63.","journal-title":"Oncogenesis"},{"issue":"19","key":"760_CR128","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.devcel.2021.09.008","volume":"56","author":"CM Brewer","year":"2021","unstructured":"Brewer CM, Nelson BR, Wakenight P, Collins SJ, Okamura DM, Dong XR, et al. Adaptations in Hippo-Yap signaling and myofibroblast fate underlie scar-free ear appendage wound healing in spiny mice. Dev Cell. 2021;56(19):2722-40.e6.","journal-title":"Dev Cell"},{"issue":"6","key":"760_CR129","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162139","volume":"133","author":"WS Ho","year":"2023","unstructured":"Ho WS, Mondal I, Xu B, Das O, Sun R, Chiou P, et al. PP2Ac\/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages. J Clin Invest. 2023;133(6): e162139.","journal-title":"J Clin Invest"},{"issue":"8","key":"760_CR130","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41589-022-01088-2","volume":"18","author":"DR Squair","year":"2022","unstructured":"Squair DR, Virdee S. A new dawn beyond lysine ubiquitination. Nat Chem Biol. 2022;18(8):802\u201311.","journal-title":"Nat Chem Biol"},{"issue":"4","key":"760_CR131","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.200611063","volume":"177","author":"X Wang","year":"2007","unstructured":"Wang X, Herr RA, Chua WJ, Lybarger L, Wiertz EJ, Hansen TH. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J Cell Biol. 2007;177(4):613\u201324.","journal-title":"J Cell Biol"},{"issue":"5731","key":"760_CR132","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1126\/science.1110340","volume":"309","author":"K Cadwell","year":"2005","unstructured":"Cadwell K, Coscoy L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science. 2005;309(5731):127\u201330.","journal-title":"Science"},{"issue":"3","key":"760_CR133","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3390\/cells3030674","volume":"3","author":"R Suryadinata","year":"2014","unstructured":"Suryadinata R, Roesley SN, Yang G, Sar\u010devi\u0107 B. Mechanisms of generating polyubiquitin chains of different topology. Cells. 2014;3(3):674\u201389.","journal-title":"Cells"},{"issue":"1","key":"760_CR134","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng L, Meng T, Chen L, Wei W, Wang P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020;5(1):11.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"760_CR135","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s43556-021-00043-2","volume":"2","author":"Q Yang","year":"2021","unstructured":"Yang Q, Zhao J, Chen D, Wang Y. E3 ubiquitin ligases: styles, structures and functions. Mol Biomed. 2021;2(1):23.","journal-title":"Mol Biomed"},{"issue":"9","key":"760_CR136","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/ph14090848","volume":"14","author":"L Cruz","year":"2021","unstructured":"Cruz L, Soares P, Correia M. Ubiquitin-specific proteases: players in cancer cellular processes. Pharmaceuticals (Basel). 2021;14(9):848.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"760_CR137","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s13046-022-02576-y","volume":"41","author":"H Yang","year":"2022","unstructured":"Yang H, Xue M, Su P, Zhou Y, Li X, Li Z, et al. RNF31 represses cell progression and immune evasion via YAP\/PD-L1 suppression in triple negative breast cancer. J Exp Clin Cancer Res. 2022;41(1):364.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"760_CR138","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12964-022-00963-8","volume":"20","author":"Z Li","year":"2022","unstructured":"Li Z, Su P, Ding Y, Gao H, Yang H, Li X, et al. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo\/YAP axis. Cell Commun Signal. 2022;20(1):164.","journal-title":"Cell Commun Signal"},{"issue":"21","key":"760_CR139","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.7150\/thno.46078","volume":"10","author":"X Zhou","year":"2020","unstructured":"Zhou X, Li Y, Wang W, Wang S, Hou J, Zhang A, et al. Regulation of Hippo\/YAP signaling and esophageal squamous carcinoma progression by an E3 ubiquitin ligase PARK2. Theranostics. 2020;10(21):9443\u201357.","journal-title":"Theranostics"},{"issue":"1","key":"760_CR140","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41420-024-01943-2","volume":"10","author":"P Zhang","year":"2024","unstructured":"Zhang P, Liu D, Zang Y, Wang J, Liu Z, Zhu J, et al. USP12 facilitates gastric cancer progression via stabilizing YAP. Cell Death Discov. 2024;10(1):174.","journal-title":"Cell Death Discov"},{"key":"760_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216439","volume":"577","author":"Z Tian","year":"2023","unstructured":"Tian Z, Xu C, He W, Lin Z, Zhang W, Tao K, et al. The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP. Cancer Lett. 2023;577: 216439.","journal-title":"Cancer Lett"},{"key":"760_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216832","volume":"589","author":"H Mo","year":"2024","unstructured":"Mo H, Li R, Yang N, Han J, Xiao X, Zhang Y, et al. USP40 promotes hepatocellular carcinoma progression through a YAP\/USP40 positive feedback loop. Cancer Lett. 2024;589: 216832.","journal-title":"Cancer Lett"},{"issue":"48","key":"760_CR143","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1038\/s41388-022-02507-3","volume":"41","author":"C Yan","year":"2022","unstructured":"Yan C, Yang H, Su P, Li X, Li Z, Wang D, et al. OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer. Oncogene. 2022;41(48):5186\u201398.","journal-title":"Oncogene"},{"issue":"11","key":"760_CR144","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.3390\/cancers12113090","volume":"12","author":"A Mussell","year":"2020","unstructured":"Mussell A, Shen H, Chen Y, Mastri M, Eng KH, Bshara W, et al. USP1 regulates TAZ protein stability through ubiquitin modifications in breast cancer. Cancers (Basel). 2020;12(11):3090.","journal-title":"Cancers (Basel)."},{"issue":"4","key":"760_CR145","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41419-023-05777-1","volume":"14","author":"D Liu","year":"2023","unstructured":"Liu D, Li Q, Zang Y, Li X, Li Z, Zhang P, et al. USP1 modulates hepatocellular carcinoma progression via the Hippo\/TAZ axis. Cell Death Dis. 2023;14(4):264.","journal-title":"Cell Death Dis"},{"issue":"8","key":"760_CR146","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.7150\/ijbs.65428","volume":"18","author":"P Yuan","year":"2022","unstructured":"Yuan P, Feng Z, Huang H, Wang G, Chen Z, Xu G, et al. USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ. Int J Biol Sci. 2022;18(8):3122\u201336.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"760_CR147","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41423-022-00969-9","volume":"20","author":"X Zhu","year":"2023","unstructured":"Zhu X, Wang P, Zhan X, Zhang Y, Sheng J, He S, et al. USP1-regulated reciprocal differentiation of Th17 cells and Treg cells by deubiquitinating and stabilizing TAZ. Cell Mol Immunol. 2023;20(3):252\u201363.","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"760_CR148","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41419-022-05417-0","volume":"13","author":"Q Yang","year":"2022","unstructured":"Yang Q, Lu Y, Shangguan J, Shu X. PSMA1 mediates tumor progression and poor prognosis of gastric carcinoma by deubiquitinating and stabilizing TAZ. Cell Death Dis. 2022;13(11):989.","journal-title":"Cell Death Dis"},{"issue":"1\u20132","key":"760_CR149","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1101\/gad.333146.119","volume":"34","author":"YS Cho","year":"2020","unstructured":"Cho YS, Li S, Wang X, Zhu J, Zhuo S, Han Y, et al. CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki\/Yap\/Taz in the nucleus. Genes Dev. 2020;34(1\u20132):53\u201371.","journal-title":"Genes Dev"},{"issue":"1","key":"760_CR150","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41467-019-08334-7","volume":"10","author":"X Sun","year":"2019","unstructured":"Sun X, Ding Y, Zhan M, Li Y, Gao D, Wang G, et al. Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie. Nat Commun. 2019;10(1):411.","journal-title":"Nat Commun"},{"issue":"8","key":"760_CR151","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/s41419-022-05113-z","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Dai Y, Ge H, Guo S, Zhang W, Wang Y, et al. The deubiquitinase USP7 promotes HNSCC progression via deubiquitinating and stabilizing TAZ. Cell Death Dis. 2022;13(8):677.","journal-title":"Cell Death Dis"},{"issue":"1","key":"760_CR152","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13046-022-02410-5","volume":"41","author":"D Wang","year":"2022","unstructured":"Wang D, Li Z, Li X, Yan C, Yang H, Zhuang T, et al. DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer. J Exp Clin Cancer Res. 2022;41(1):219.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"760_CR153","doi-asserted-by":"publisher","first-page":"417","DOI":"10.7150\/ijbs.54194","volume":"17","author":"J Tang","year":"2021","unstructured":"Tang J, Tian Z, Liao X, Wu G. SOX13\/TRIM11\/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer. Int J Biol Sci. 2021;17(2):417\u201329.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"760_CR154","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1158\/0008-5472.CAN-19-2388","volume":"80","author":"H Zhu","year":"2020","unstructured":"Zhu H, Yan F, Yuan T, Qian M, Zhou T, Dai X, et al. USP10 promotes proliferation of hepatocellular carcinoma by deubiquitinating and stabilizing YAP\/TAZ. Cancer Res. 2020;80(11):2204\u201316.","journal-title":"Cancer Res"},{"issue":"1","key":"760_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-022-01040-w","volume":"30","author":"C Zhao","year":"2023","unstructured":"Zhao C, Gong J, Bai Y, Yin T, Zhou M, Pan S, et al. A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma. Cell Death Differ. 2023;30(1):1\u201315.","journal-title":"Cell Death Differ"},{"issue":"4","key":"760_CR156","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41419-022-04781-1","volume":"13","author":"J Tang","year":"2022","unstructured":"Tang J, Luo Y, Xiao L. USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ. Cell Death Dis. 2022;13(4):326.","journal-title":"Cell Death Dis"},{"issue":"2","key":"760_CR157","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s13238-019-00674-w","volume":"11","author":"B Pan","year":"2020","unstructured":"Pan B, Yang Y, Li J, Wang Y, Fang C, Yu FX, et al. USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer. Protein Cell. 2020;11(2):138\u201343.","journal-title":"Protein Cell"},{"issue":"1","key":"760_CR158","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41420-024-02136-7","volume":"10","author":"Y Sun","year":"2024","unstructured":"Sun Y, Liu D, Zhang X, Su P, Li X, Li Z, et al. Regulation of Hippo\/YAP axis in colon cancer progression by the deubiquitinase JOSD1. Cell Death Discov. 2024;10(1):365.","journal-title":"Cell Death Discov"},{"issue":"12","key":"760_CR159","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1016\/j.apsb.2021.04.003","volume":"11","author":"M Qian","year":"2021","unstructured":"Qian M, Yan F, Wang W, Du J, Yuan T, Wu R, et al. Deubiquitinase JOSD2 stabilizes YAP\/TAZ to promote cholangiocarcinoma progression. Acta Pharm Sin B. 2021;11(12):4008\u201319.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"760_CR160","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.dld.2023.06.026","volume":"56","author":"Z Guo","year":"2024","unstructured":"Guo Z, Guo L. OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession. Dig Liver Dis. 2024;56(2):352\u201362.","journal-title":"Dig Liver Dis"},{"key":"760_CR161","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1476-4598-13-110","volume":"13","author":"K Tu","year":"2014","unstructured":"Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C, et al. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Mol Cancer. 2014;13:110.","journal-title":"Mol Cancer"},{"issue":"1","key":"760_CR162","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-024-06464-5","volume":"15","author":"Y Gu","year":"2024","unstructured":"Gu Y, Wu S, Fan J, Meng Z, Gao G, Liu T, et al. CYLD regulates cell ferroptosis through Hippo\/YAP signaling in prostate cancer progression. Cell Death Dis. 2024;15(1):79.","journal-title":"Cell Death Dis"},{"issue":"2","key":"760_CR163","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neo.2019.12.001","volume":"22","author":"A Zhang","year":"2020","unstructured":"Zhang A, Wang W, Chen Z, Pang D, Zhou X, Lu K, et al. SHARPIN inhibits esophageal squamous cell carcinoma progression by modulating hippo signaling. Neoplasia. 2020;22(2):76\u201385.","journal-title":"Neoplasia"},{"issue":"3","key":"760_CR164","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41389-020-0220-5","volume":"9","author":"Z Wang","year":"2020","unstructured":"Wang Z, Kong Q, Su P, Duan M, Xue M, Li X, et al. Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187. Oncogenesis. 2020;9(3):36.","journal-title":"Oncogenesis"},{"issue":"20","key":"760_CR165","doi-asserted-by":"publisher","first-page":"11912","DOI":"10.1111\/jcmm.15811","volume":"24","author":"D Pang","year":"2020","unstructured":"Pang D, Wang W, Zhou X, Lu K, Zhang J, Chen Z, et al. RACO-1 modulates Hippo signalling in oesophageal squamous cell carcinoma. J Cell Mol Med. 2020;24(20):11912\u201321.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"760_CR166","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41419-025-07599-9","volume":"16","author":"C Lu","year":"2025","unstructured":"Lu C, Liu H, Liu T, Sun S, Zheng Y, Ling T, et al. RIPK2 promotes colorectal cancer metastasis by protecting YAP degradation from ITCH-mediated ubiquitination. Cell Death Dis. 2025;16(1):248.","journal-title":"Cell Death Dis"},{"issue":"12","key":"760_CR167","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41419-022-05474-5","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Luo J, Xiao Z, Zang Y, Li X, Zhou Y, et al. USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP. Cell Death Dis. 2022;13(12):1021.","journal-title":"Cell Death Dis"},{"issue":"9","key":"760_CR168","first-page":"4222","volume":"13","author":"S Wang","year":"2023","unstructured":"Wang S, Liu K, Han X, Cheng Y, Zhao E, Brat DJ, et al. ATXN3 deubiquitinates YAP1 to promote tumor growth. Am J Cancer Res. 2023;13(9):4222\u201334.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"760_CR169","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12964-023-01073-9","volume":"21","author":"L Wu","year":"2023","unstructured":"Wu L, Ou Z, Liu P, Zhao C, Tong S, Wang R, et al. ATXN3 promotes prostate cancer progression by stabilizing YAP. Cell Commun Signal. 2023;21(1):152.","journal-title":"Cell Commun Signal"},{"issue":"12","key":"760_CR170","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-19-3718","volume":"80","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Zhou H, Ponzoni L, Luo A, Zhu R, He M, et al. EIF3H orchestrates hippo pathway-mediated oncogenesis via catalytic control of YAP stability. Cancer Res. 2020;80(12):2550\u201363.","journal-title":"Cancer Res"},{"issue":"1","key":"760_CR171","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2018.10.030","volume":"73","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Du J, Wang S, Shao L, Jin K, Li F, et al. OTUB2 promotes cancer metastasis via hippo-independent activation of YAP and TAZ. Mol Cell. 2019;73(1):7-21 e7.","journal-title":"Mol Cell"},{"issue":"5","key":"760_CR172","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1111\/cas.15326","volume":"113","author":"X Liu","year":"2022","unstructured":"Liu X, Chen B, Chen J, Su Z, Sun S. Deubiquitinase ubiquitin-specific peptidase 10 maintains cysteine rich angiogenic inducer 61 expression via Yes1 associated transcriptional regulator to augment immune escape and metastasis of pancreatic adenocarcinoma. Cancer Sci. 2022;113(5):1868\u201379.","journal-title":"Cancer Sci"},{"issue":"5","key":"760_CR173","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/s41418-023-01134-z","volume":"30","author":"J Tang","year":"2023","unstructured":"Tang J, Yang Q, Mao C, Xiao D, Liu S, Xiao L, et al. The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway. Cell Death Differ. 2023;30(5):1247\u201359.","journal-title":"Cell Death Differ"},{"issue":"18","key":"760_CR174","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1038\/s41388-018-0134-2","volume":"37","author":"L Li","year":"2018","unstructured":"Li L, Liu T, Li Y, Wu C, Luo K, Yin Y, et al. The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization. Oncogene. 2018;37(18):2422\u201331.","journal-title":"Oncogene"},{"issue":"1","key":"760_CR175","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41467-023-37671-x","volume":"14","author":"R Li","year":"2023","unstructured":"Li R, Shao J, Jin YJ, Kawase H, Ong YT, Troidl K, et al. Endothelial FAT1 inhibits angiogenesis by controlling YAP\/TAZ protein degradation via E3 ligase MIB2. Nat Commun. 2023;14(1):1980.","journal-title":"Nat Commun"},{"issue":"1","key":"760_CR176","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12951-023-02070-3","volume":"21","author":"J Qi","year":"2023","unstructured":"Qi J, Zhang X, Zhang S, Wu S, Lu Y, Li S, et al. P65 mediated UBR4 in exosomes derived from menstrual blood stromal cells to reduce endometrial fibrosis by regulating YAP Ubiquitination. J Nanobiotechnol. 2023;21(1):305.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"760_CR177","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s12276-022-00920-y","volume":"55","author":"Z Wu","year":"2023","unstructured":"Wu Z, Zhu L, Nie X, Wei L, Qi Y. USP15 promotes pulmonary vascular remodeling in pulmonary hypertension in a YAP1\/TAZ-dependent manner. Exp Mol Med. 2023;55(1):183\u201395.","journal-title":"Exp Mol Med"},{"issue":"3","key":"760_CR178","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.7150\/thno.98660","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Chen X, Xu X, Chen C, Min M, Liang D, et al. OTUB2 contributes to vascular calcification in chronic kidney disease via the YAP-mediated transcription of PFKFB3. Theranostics. 2025;15(3):1185\u2013204.","journal-title":"Theranostics"},{"key":"760_CR179","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3389\/fimmu.2019.01107","volume":"10","author":"T Dainichi","year":"2019","unstructured":"Dainichi T, Matsumoto R, Mostafa A, Kabashima K. Immune control by TRAF6-mediated pathways of epithelial cells in the EIME (epithelial immune microenvironment). Front Immunol. 2019;10:1107.","journal-title":"Front Immunol"},{"issue":"5","key":"760_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107990","volume":"32","author":"M Liu","year":"2020","unstructured":"Liu M, Yan M, Lv H, Wang B, Lv X, Zhang H, et al. Macrophage K63-linked ubiquitination of YAP promotes its nuclear localization and exacerbates atherosclerosis. Cell Rep. 2020;32(5): 107990.","journal-title":"Cell Rep"},{"key":"760_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216861","volume":"590","author":"L Wang","year":"2024","unstructured":"Wang L, Liu X, Han Y, Tsai HI, Dan Z, Yang P, et al. TRAF6 enhances PD-L1 expression through YAP1-TFCP2 signaling in melanoma. Cancer Lett. 2024;590: 216861.","journal-title":"Cancer Lett"},{"issue":"24","key":"760_CR182","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153943","volume":"132","author":"DK Panda","year":"2022","unstructured":"Panda DK, Bai X, Zhang Y, Stylianesis NA, Koromilas AE, Lipman ML, et al. SCF-SKP2 E3 ubiquitin ligase links mTORC1\/ER stress\/ISR with YAP activation in murine renal cystogenesis. J Clin Invest. 2022;132(24): e153943.","journal-title":"J Clin Invest"},{"issue":"1","key":"760_CR183","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1038\/s41467-018-04620-y","volume":"9","author":"F Yao","year":"2018","unstructured":"Yao F, Zhou Z, Kim J, Hang Q, Xiao Z, Ton BN, et al. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity. Nat Commun. 2018;9(1):2269.","journal-title":"Nat Commun"},{"issue":"1","key":"760_CR184","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41420-022-01119-w","volume":"8","author":"H Liu","year":"2022","unstructured":"Liu H, Zhong L, Lu Y, Liu X, Wei J, Ding Y, et al. Deubiquitylase OTUD1 confers Erlotinib sensitivity in non-small cell lung cancer through inhibition of nuclear translocation of YAP1. Cell Death Discov. 2022;8(1):403.","journal-title":"Cell Death Discov"},{"issue":"791","key":"760_CR185","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adq1735","volume":"17","author":"Z Li","year":"2025","unstructured":"Li Z, Zhang W, Wei XY, Hu JZ, Hu X, Liu H, et al. TRIM15 drives chondrocyte senescence and osteoarthritis progression. Sci Transl Med. 2025;17(791): eadq1735.","journal-title":"Sci Transl Med."},{"issue":"4","key":"760_CR186","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1152\/physrev.00025.2019","volume":"100","author":"HM Chang","year":"2020","unstructured":"Chang HM, Yeh ETH. SUMO: from bench to bedside. Physiol Rev. 2020;100(4):1599\u2013619.","journal-title":"Physiol Rev"},{"issue":"6","key":"760_CR187","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.molcel.2008.11.019","volume":"32","author":"E Lapi","year":"2008","unstructured":"Lapi E, Di Agostino S, Donzelli S, Gal H, Domany E, Rechavi G, et al. PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell. 2008;32(6):803\u201314.","journal-title":"Mol Cell"},{"issue":"4","key":"760_CR188","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/cas.15285","volume":"113","author":"CK Sinclear","year":"2022","unstructured":"Sinclear CK, Maruyama J, Nagashima S, Arimoto-Matsuzaki K, Kuleape JA, Iwasa H, et al. Protein kinase C\u03b1 activation switches YAP1 from TEAD-mediated signaling to p73-mediated signaling. Cancer Sci. 2022;113(4):1305\u201320.","journal-title":"Cancer Sci"},{"issue":"4","key":"760_CR189","first-page":"1207","volume":"10","author":"B Wang","year":"2020","unstructured":"Wang B, Shao W, Shi Y, Liao J, Chen X, Wang C. Verteporfin induced SUMOylation of YAP1 in endometrial cancer. Am J Cancer Res. 2020;10(4):1207\u201317.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"760_CR190","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00018-023-05050-w","volume":"81","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Liang M, Chen L, Wang J, Huang Y, Huo H, et al. Myeloid SENP3 deficiency protects mice from diet and age-induced obesity via regulation of YAP1 SUMOylation. Cell Mol Life Sci. 2023;81(1):4.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"760_CR191","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12967-021-03007-w","volume":"19","author":"X Deng","year":"2021","unstructured":"Deng X, Fu X, Teng H, Fang L, Liang B, Zeng R, et al. E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1. J Transl Med. 2021;19(1):332.","journal-title":"J Transl Med"},{"key":"760_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101830","volume":"40","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhou H, Wang Y, Gui J, Yang D, Sun J, et al. H3K27 acetylation activated-PDLIM7 promotes castration-resistant prostate cancer progression by inducing O-Glycosylation of YAP1 protein. Transl Oncol. 2024;40: 101830.","journal-title":"Transl Oncol"},{"issue":"1","key":"760_CR193","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13578-023-00993-w","volume":"13","author":"Z Wu","year":"2023","unstructured":"Wu Z, Ge L, Ma L, Lu M, Song Y, Deng S, et al. TPM2 attenuates progression of prostate cancer by blocking PDLIM7-mediated nuclear translocation of YAP1. Cell Biosci. 2023;13(1):39.","journal-title":"Cell Biosci"},{"issue":"4","key":"760_CR194","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/cmi.2016.66","volume":"14","author":"MM Hu","year":"2017","unstructured":"Hu MM, Shu HB. Multifaceted roles of TRIM38 in innate immune and inflammatory responses. Cell Mol Immunol. 2017;14(4):331\u20138.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"760_CR195","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41420-022-00842-8","volume":"8","author":"X Xue","year":"2022","unstructured":"Xue X, Tian X, Zhang C, Miao Y, Wang Y, Peng Y, et al. YAP ISGylation increases its stability and promotes its positive regulation on PPP by stimulating 6PGL transcription. Cell Death Discov. 2022;8(1):59.","journal-title":"Cell Death Discov"},{"issue":"8","key":"760_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107512","volume":"300","author":"M Chen","year":"2024","unstructured":"Chen M, Liu Y, Zuo M, Guo C, Du Y, Xu H, et al. NEDD8 enhances Hippo signaling by mediating YAP1 neddylation. J Biol Chem. 2024;300(8): 107512.","journal-title":"J Biol Chem"},{"issue":"6","key":"760_CR197","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","volume":"15","author":"C Reily","year":"2019","unstructured":"Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol. 2019;15(6):346\u201366.","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"760_CR198","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/s12276-021-00709-5","volume":"53","author":"BE Lee","year":"2021","unstructured":"Lee BE, Suh PG, Kim JI. O-GlcNAcylation in health and neurodegenerative diseases. Exp Mol Med. 2021;53(11):1674\u201382.","journal-title":"Exp Mol Med"},{"issue":"30","key":"760_CR199","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1038\/s41388-021-01901-7","volume":"40","author":"X Li","year":"2021","unstructured":"Li X, Wu Z, He J, Jin Y, Chu C, Cao Y, et al. OGT regulated O-GlcNAcylation promotes papillary thyroid cancer malignancy via activating YAP. Oncogene. 2021;40(30):4859\u201371.","journal-title":"Oncogene"},{"issue":"3","key":"760_CR200","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.molcel.2017.10.010","volume":"68","author":"C Peng","year":"2017","unstructured":"Peng C, Zhu Y, Zhang W, Liao Q, Chen Y, Zhao X, et al. Regulation of the Hippo-YAP pathway by glucose sensor O-GlcNAcylation. Mol Cell. 2017;68(3):591-604.e5.","journal-title":"Mol Cell"},{"key":"760_CR201","doi-asserted-by":"publisher","first-page":"15280","DOI":"10.1038\/ncomms15280","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang X, Qiao Y, Wu Q, Chen Y, Zou S, Liu X, et al. The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis. Nat Commun. 2017;8:15280.","journal-title":"Nat Commun"},{"issue":"11","key":"760_CR202","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407494","volume":"12","author":"X Cui","year":"2025","unstructured":"Cui X, Zhu Y, Zeng L, Zhang M, Uddin A, Gillespie TW, et al. Pharmacological dissection identifies retatrutide overcomes the therapeutic barrier of obese TNBC treatments through suppressing the interplay between glycosylation and ubiquitylation of YAP. Adv Sci (Weinh). 2025;12(11): e2407494.","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"760_CR203","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25(6):424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"760_CR204","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41420-021-00468-2","volume":"7","author":"G Zhu","year":"2021","unstructured":"Zhu G, Murshed A, Li H, Ma J, Zhen N, Ding M, et al. O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP\/TFRC pathway in liver cancer. Cell Death Discov. 2021;7(1):83.","journal-title":"Cell Death Discov"},{"issue":"12","key":"760_CR205","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.7150\/thno.55482","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Yu K, Ma L, Qian Z, Tian X, Miao Y, et al. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma. Theranostics. 2021;11(12):5650\u201374.","journal-title":"Theranostics"},{"issue":"1","key":"760_CR206","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41392-024-01805-4","volume":"9","author":"H Qian","year":"2024","unstructured":"Qian H, Ding CH, Liu F, Chen SJ, Huang CK, Xiao MC, et al. SRY-Box transcription factor 9 triggers YAP nuclear entry via direct interaction in tumors. Signal Transduct Target Ther. 2024;9(1):96.","journal-title":"Signal Transduct Target Ther"},{"key":"760_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118121","volume":"261","author":"TH Xu","year":"2020","unstructured":"Xu TH, Sheng Z, Li Y, Qiu X, Tian B, Yao L. OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP. Life Sci. 2020;261: 118121.","journal-title":"Life Sci"},{"issue":"1","key":"760_CR208","doi-asserted-by":"publisher","first-page":"9334","DOI":"10.1038\/s41467-024-53601-x","volume":"15","author":"Y Lei","year":"2024","unstructured":"Lei Y, Liu Q, Chen B, Wu F, Li Y, Dong X, et al. Protein O-GlcNAcylation coupled to Hippo signaling drives vascular dysfunction in diabetic retinopathy. Nat Commun. 2024;15(1):9334.","journal-title":"Nat Commun"},{"key":"760_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2024.124764","volume":"360","author":"MY Zhang","year":"2024","unstructured":"Zhang MY, Wei TT, Han C, Tan CY, Xie TH, Cai J, et al. YAP O-GlcNAcylation contributes to corneal epithelial cell ferroptosis under cigarette smoke exposure. Environ Pollut. 2024;360: 124764.","journal-title":"Environ Pollut"},{"issue":"1","key":"760_CR210","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13046-023-02711-3","volume":"42","author":"Y Cui","year":"2023","unstructured":"Cui Y, Li J, Zhang P, Yin D, Wang Z, Dai J, et al. B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma. J Exp Clin Cancer Res. 2023;42(1):146.","journal-title":"J Exp Clin Cancer Res"},{"key":"760_CR211","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.semcancer.2021.03.015","volume":"83","author":"IG Park","year":"2022","unstructured":"Park IG, Jeon M, Kim H, Lee JM. Coordinated methyl readers: functional communications in cancer. Semin Cancer Biol. 2022;83:88\u201399.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"760_CR212","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccell.2018.06.002","volume":"34","author":"L Fang","year":"2018","unstructured":"Fang L, Teng H, Wang Y, Liao G, Weng L, Li Y, et al. SET1A-mediated mono-methylation at K342 regulates YAP activation by blocking its nuclear export and promotes tumorigenesis. Cancer Cell. 2018;34(1):103-18.e9.","journal-title":"Cancer Cell"},{"issue":"11","key":"760_CR213","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/cac2.12609","volume":"44","author":"J Jiang","year":"2024","unstructured":"Jiang J, Ye P, Sun N, Zhu W, Yang M, Yu M, et al. Yap methylation-induced FGL1 expression suppresses anti-tumor immunity and promotes tumor progression in KRAS-driven lung adenocarcinoma. Cancer Commun (Lond). 2024;44(11):1350\u201373.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"760_CR214","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1038\/s41467-021-26967-5","volume":"12","author":"Y Gu","year":"2021","unstructured":"Gu Y, Chen Y, Wei L, Wu S, Shen K, Liu C, et al. ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation. Nat Commun. 2021;12(1):6711.","journal-title":"Nat Commun"},{"issue":"2","key":"760_CR215","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.devcel.2013.05.025","volume":"26","author":"MJ Oudhoff","year":"2013","unstructured":"Oudhoff MJ, Freeman SA, Couzens AL, Antignano F, Kuznetsova E, Min PH, et al. Control of the hippo pathway by Set7-dependent methylation of Yap. Dev Cell. 2013;26(2):188\u201394.","journal-title":"Dev Cell"},{"issue":"17","key":"760_CR216","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1093\/cvr\/cvac102","volume":"118","author":"S Ambrosini","year":"2023","unstructured":"Ambrosini S, Montecucco F, Kolijn D, Pedicino D, Akhmedov A, Mohammed SA, et al. Methylation of the Hippo effector YAP by the methyltransferase SETD7 drives myocardial ischaemic injury: a translational study. Cardiovasc Res. 2023;118(17):3374\u201385.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"760_CR217","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jcmgh.2021.10.012","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen S, Wu H, Wang Z, Jia M, Guo J, Jin J, et al. Loss of SPTBN1 suppresses autophagy Via SETD7-mediated YAP methylation in hepatocellular carcinoma initiation and development. Cell Mol Gastroenterol Hepatol. 2022;13(3):949-73.e7.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"760_CR218","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41419-024-06666-x","volume":"15","author":"M Zhang","year":"2024","unstructured":"Zhang M, Cai F, Guo J, Liu S, Ma G, Cai M, et al. ACAT2 suppresses the ubiquitination of YAP1 to enhance the proliferation and metastasis ability of gastric cancer via the upregulation of SETD7. Cell Death Dis. 2024;15(4):297.","journal-title":"Cell Death Dis"},{"issue":"1","key":"760_CR219","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41467-024-55769-8","volume":"16","author":"XL Hong","year":"2025","unstructured":"Hong XL, Huang CK, Qian H, Ding CH, Liu F, Hong HY, et al. Positive feedback between arginine methylation of YAP and methionine transporter SLC43A2 drives anticancer drug resistance. Nat Commun. 2025;16(1):87.","journal-title":"Nat Commun"},{"issue":"26","key":"760_CR220","doi-asserted-by":"publisher","first-page":"22089","DOI":"10.1074\/jbc.M111.334714","volume":"287","author":"S Hata","year":"2012","unstructured":"Hata S, Hirayama J, Kajiho H, Nakagawa K, Hata Y, Katada T, et al. A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents. J Biol Chem. 2012;287(26):22089\u201398.","journal-title":"J Biol Chem"},{"issue":"11","key":"760_CR221","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/onc.2013.88","volume":"33","author":"B Mao","year":"2014","unstructured":"Mao B, Hu F, Cheng J, Wang P, Xu M, Yuan F, et al. SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma. Oncogene. 2014;33(11):1468\u201374.","journal-title":"Oncogene"},{"issue":"1","key":"760_CR222","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s11658-024-00636-z","volume":"29","author":"X Gan","year":"2024","unstructured":"Gan X, Feng Y, Liu Y, Lin X, Yu X, Rong X, et al. Identification of zinc finger MIZ-type containing 2 as an oncoprotein enhancing NAD-dependent protein deacetylase sirtuin-1 deacetylase activity to regulate Wnt and Hippo pathways in non-small-cell lung cancer. Cell Mol Biol Lett. 2024;29(1):122.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"760_CR223","doi-asserted-by":"publisher","first-page":"8056","DOI":"10.1038\/s41467-023-43775-1","volume":"14","author":"A Claude-Taupin","year":"2023","unstructured":"Claude-Taupin A, Isnard P, Bagattin A, Kuperwasser N, Roccio F, Ruscica B, et al. The AMPK-Sirtuin 1-YAP axis is regulated by fluid flow intensity and controls autophagy flux in kidney epithelial cells. Nat Commun. 2023;14(1):8056.","journal-title":"Nat Commun"},{"issue":"2","key":"760_CR224","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41419-020-2343-1","volume":"11","author":"P Yuan","year":"2020","unstructured":"Yuan P, Hu Q, He X, Long Y, Song X, Wu F, et al. Laminar flow inhibits the Hippo\/YAP pathway via autophagy and SIRT1-mediated deacetylation against atherosclerosis. Cell Death Dis. 2020;11(2):141.","journal-title":"Cell Death Dis"},{"issue":"8","key":"760_CR225","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/pharmaceutics14081659","volume":"14","author":"YS Kim","year":"2022","unstructured":"Kim YS, Kim M, Cho DI, Lim SY, Jun JH, Kim MR, et al. PSME4 degrades acetylated YAP1 in the nucleus of mesenchymal stem cells. Pharmaceutics. 2022;14(8):1659.","journal-title":"Pharmaceutics"},{"key":"760_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106666","volume":"188","author":"S Zhang","year":"2023","unstructured":"Zhang S, Guo M, Jiang X, Tang L, Wu T, Bi G, et al. PXR triggers YAP-TEAD binding and Sirt2-driven YAP deacetylation and polyubiquitination to promote liver enlargement and regeneration in mice. Pharmacol Res. 2023;188: 106666.","journal-title":"Pharmacol Res"},{"key":"760_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107573","volume":"211","author":"P Wang","year":"2025","unstructured":"Wang P, Wang L, Liu C, Hu Y, Feng G, Lian Z, et al. YAP K236 acetylation facilitates its nucleic export and deprived the protection against cardiac hypertrophy in mice. Pharmacol Res. 2025;211: 107573.","journal-title":"Pharmacol Res"},{"issue":"1","key":"760_CR228","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.123.067646","volume":"151","author":"S Liu","year":"2025","unstructured":"Liu S, Deshmukh V, Meng F, Wang Y, Morikawa Y, Steimle JD, et al. Microtubules sequester acetylated YAP in the cytoplasm and inhibit heart regeneration. Circulation. 2025;151(1):59\u201375.","journal-title":"Circulation"},{"key":"760_CR229","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s13402-023-00910-w","volume":"47","author":"G Kim","year":"2023","unstructured":"Kim G, Bhattarai PY, Lim SC, Lee KY, Choi HS. Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development. Cell Oncol (Dordr). 2023;47:967.","journal-title":"Cell Oncol (Dordr)"},{"issue":"7779","key":"760_CR230","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"key":"760_CR231","doi-asserted-by":"publisher","DOI":"10.1172\/JCI174587","volume":"134","author":"J Ju","year":"2024","unstructured":"Ju J, Zhang H, Lin M, Yan Z, An L, Cao Z, et al. The alanyl-tRNA synthetase AARS1 moonlights as a lactyl-transferase to promote YAP signaling in gastric cancer. J Clin Invest. 2024;134: e174587.","journal-title":"J Clin Invest"},{"issue":"2","key":"760_CR232","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/JS9.0000000000000879","volume":"110","author":"T Yin","year":"2024","unstructured":"Yin T, Wen J, Zhen T, Liao Y, Zhang Z, Zhu H, et al. Long-term quality of life between duodenum-preserving pancreatic head resection and pancreatoduodenectomy: a systematic review and meta-analysis. Int J Surg (London, England). 2024;110(2):1139\u201348.","journal-title":"Int J Surg (London, England)"},{"key":"760_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217386","volume":"611","author":"L Wang","year":"2024","unstructured":"Wang L, Zeng T, Wang Y, Wang G, Yu W, Zhang J, et al. K90 lactylation orchestrates YAP nuclear sequestration by impairing binding with exportin CRM1 and enhances HCC malignancy. Cancer Lett. 2024;611: 217386.","journal-title":"Cancer Lett"},{"issue":"8","key":"760_CR234","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/oxfordjournals.molbev.a026406","volume":"17","author":"A Miseta","year":"2000","unstructured":"Miseta A, Csutora P. Relationship between the occurrence of cysteine in proteins and the complexity of organisms. Mol Biol Evol. 2000;17(8):1232\u20139.","journal-title":"Mol Biol Evol"},{"issue":"35","key":"760_CR235","doi-asserted-by":"publisher","first-page":"13086","DOI":"10.1073\/pnas.0603290103","volume":"103","author":"NL Reynaert","year":"2006","unstructured":"Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C, et al. Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci USA. 2006;103(35):13086\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"760_CR236","doi-asserted-by":"publisher","first-page":"11596","DOI":"10.1074\/jbc.M115.712539","volume":"291","author":"RK Gandhirajan","year":"2016","unstructured":"Gandhirajan RK, Jain M, Walla B, Johnsen M, Bartram MP, Huynh Anh M, et al. Cysteine S-glutathionylation promotes stability and activation of the hippo downstream effector transcriptional co-activator with PDZ-binding Motif (TAZ). J Biol Chem. 2016;291(22):11596\u2013607.","journal-title":"J Biol Chem"},{"issue":"10","key":"760_CR237","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140781","volume":"10","author":"KK Slemmons","year":"2015","unstructured":"Slemmons KK, Crose LE, Rudzinski E, Bentley RC, Linardic CM. Role of the YAP oncoprotein in priming ras-driven rhabdomyosarcoma. PLoS ONE. 2015;10(10): e0140781.","journal-title":"PLoS ONE"},{"issue":"397","key":"760_CR238","doi-asserted-by":"publisher","first-page":"ra98","DOI":"10.1126\/scisignal.aac5418","volume":"8","author":"H Zhang","year":"2015","unstructured":"Zhang H, Ramakrishnan SK, Triner D, Centofanti B, Maitra D, Gy\u0151rffy B, et al. Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1. Sci Signal. 2015;8(397):ra98.","journal-title":"Sci Signal."},{"issue":"17","key":"760_CR239","doi-asserted-by":"publisher","first-page":"28628","DOI":"10.18632\/oncotarget.15614","volume":"8","author":"VR Dasari","year":"2017","unstructured":"Dasari VR, Mazack V, Feng W, Nash J, Carey DJ, Gogoi R. Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells. Oncotarget. 2017;8(17):28628\u201340.","journal-title":"Oncotarget"},{"issue":"5","key":"760_CR240","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.375","volume":"4","author":"L Lv","year":"2023","unstructured":"Lv L, Zhou X. Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential. MedComm. 2023;4(5): e375.","journal-title":"MedComm"},{"issue":"8_Supplement","key":"760_CR241","doi-asserted-by":"publisher","first-page":"LB319","DOI":"10.1158\/1538-7445.AM2023-LB319","volume":"83","author":"T Schmelzle","year":"2023","unstructured":"Schmelzle T, Chapeau E, Bauer D, Chene P, Faris J, Fernandez C, et al. Abstract LB319: IAG933, a selective and orally efficacious YAP1\/WWTR1(TAZ)-panTEAD protein-protein interaction inhibitor with pre-clinical activity in monotherapy and combinations. Cancer Res. 2023;83(8_Supplement):LB319.","journal-title":"Cancer Res"},{"issue":"7","key":"760_CR242","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s43018-024-00754-9","volume":"5","author":"EA Chapeau","year":"2024","unstructured":"Chapeau EA, Sansregret L, Galli GG, Ch\u00e8ne P, Wartmann M, Mourikis TP, et al. Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers. Nat Cancer. 2024;5(7):1102\u201320.","journal-title":"Nat Cancer"},{"issue":"8_Supplement","key":"760_CR243","doi-asserted-by":"publisher","first-page":"CT006","DOI":"10.1158\/1538-7445.AM2023-CT006","volume":"83","author":"TA Yap","year":"2023","unstructured":"Yap TA, Kwiatkowski DJ, Desai J, Dagogo-Jack I, Millward M, Kindler HL, et al. Abstract CT006: First-in-class, first-in-human phase 1 trial of VT3989, an inhibitor of yes-associated protein (YAP)\/transcriptional enhancer activator domain (TEAD), in patients (pts) with advanced solid tumors enriched for malignant mesothelioma and other tumors with neurofibromatosis 2 (NF2) mutations. Cancer Res. 2023;83(8_Supplement):CT006.","journal-title":"Cancer Res"},{"issue":"7_Supplement","key":"760_CR244","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1158\/1538-7445.AM2023-3852","volume":"83","author":"D Hidalgo","year":"2023","unstructured":"Hidalgo D, Sanchez-Martin M, Rajurkar M, Punkosdy G, Ecsedy J, Xu L. Abstract 3852: IK-930, a paralog-selective novel TEAD-inhibitor, effectively attenuates drug-tolerant persister cell proliferation. Cancer Res. 2023;83(7_Supplement):3852.","journal-title":"Cancer Res"},{"issue":"16_Suppl","key":"760_CR245","doi-asserted-by":"publisher","first-page":"TPS3168","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS3168","volume":"40","author":"AW Tolcher","year":"2022","unstructured":"Tolcher AW, Lakhani NJ, McKean M, Lingaraj T, Victor L, Sanchez-Martin M, et al. A phase 1, first-in-human study of IK-930, an oral TEAD inhibitor targeting the Hippo pathway in subjects with advanced solid tumors. J Clin Oncol. 2022;40(16_Suppl):TPS3168.","journal-title":"J Clin Oncol"},{"key":"760_CR246","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106523","volume":"186","author":"U Sharma","year":"2022","unstructured":"Sharma U, Tuli HS, Uttam V, Choudhary R, Sharma B, Sharma U, et al. Role of Hedgehog and Hippo signaling pathways in cancer: a special focus on non-coding RNAs. Pharmacol Res. 2022;186: 106523.","journal-title":"Pharmacol Res"},{"issue":"11","key":"760_CR247","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41556-021-00781-z","volume":"23","author":"Y Li","year":"2021","unstructured":"Li Y, Qiu X, Wang X, Liu H, Geck RC, Tewari AK, et al. FGFR-inhibitor-mediated dismissal of SWI\/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance. Nat Cell Biol. 2021;23(11):1187\u201398.","journal-title":"Nat Cell Biol"}],"container-title":["Cellular & Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00760-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00760-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00760-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:55:55Z","timestamp":1757253355000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-025-00760-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":247,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["760"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00760-4","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final version of the manuscript and its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}